SawayaMEPriceVH. Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol1997; 109:296–300.
2.
ScottMJScottAM. Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis1992; 50:113–116.
3.
SawayaMEPenneysNS. Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol1991; 19:309–314.
4.
SchweikertHUWilsonJD. Regulation of human hair growth by steroid hormones: 11. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab1974; 39:1012–1019.
5.
SawayaMEHonigLSGarlandLD. 3B-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp of malepattern baldness. J Invest Dermatol1988; 91:101–105.
6.
AndersonSBishopRWRussellDW. Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem1989; 264:16249–16252.
7.
ItamiSKurataSSonodaT. Characterization of 5α-reductase in cultured human dermal papilla cells from beard and occipital hair. J Invest Dermatol1991; 96:57–59.
8.
KaufmanKDOlsenEAWhitingDA. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol1998; 39:578–589.
9.
OhHSSmartRC. An estrogen receptor mediated pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Nal Acad Sci USA1996; 93:12525–12530.
10.
SchweikertHUWilsonJD. Aromatization of androstenedione by isolated human hairs. J Clin Endocrinol Metab1975;40:413–417.
11.
SawayaME. Purification of androgen receptors in human sebocytes and hair. J Invest Dermatol1992; 98:92–96.
12.
SawayaMELewisLAHsiaSL. Presence of a converting factor for androgen receptor proteins in isolated human hair follicles and sebaceous glands. FASEB J1989; 2:4765–4767.
13.
GrodyWSchraderWO'MalleyB. Activation, transformation, and subunit structure of steroid hormone receptors. Endocrinol Rev1982; 3:141–152.
14.
PelegSSchraaderWTO'MalleyB. Sulfhydryl group content of chicken progesterone receptor. Effect of oxidation on DNA binding activity. Biochemistry1988; 27:358–362.
15.
SawayaMEShalitaAR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg1998; 3:9–15.
16.
HardyDOScherHIBogenreiderT. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab1996; 81:4400–4405.
StamatiadisDBulteau-PortoisMCMowszowiczI. Inhibition of 5α-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol1988; 19:627–632.
19.
AbramowiczM. Propecia and Rogaine extra strength for alopecia. Med Lett1998; 40:25–27.
20.
KidwaiBJGeorgeM. Hair loss and minoxidil withdrawal. Lancet1992; 340:609–610.
21.
DianiARMulhollandMjShullKL. Hair growth effects of oral administration of finasteride, a steroid 5-alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. J Clin Endocrinol Metab1992; 74:345–350.
22.
BramsonHNHermannDBatchelorKW. The unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther1997; 282(3):1496–1502.
23.
Pure encapsulations. Sudbury, MA, 199826a. Hair Regrowth: The Less Research Treatments@regrowth.com.
24.
CarraroJCRaynaudJPKochG. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1098 patients. Prostate1996; 29:231–240.
25.
StauchGPerlesPVergultG. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5alpha reductase in healthy male volunteeers. Eur Urol1994; 26:247–252.
26.
CashT. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol1992; 26:926–931.
